{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:49:01Z","timestamp":1777409341450,"version":"3.51.4"},"reference-count":56,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","award":["RC-2024-2790151 Project"],"award-info":[{"award-number":["RC-2024-2790151 Project"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background\/Objective: This study aimed to assess the prognostic significance of pretreatment nutritional and systemic inflammatory indices (IIs), and body composition parameters in patients with locally advanced cervical cancer (LACC) treated with chemoradiation and brachytherapy. The goal was to identify key predictors of clinical outcomes, such as local control (LC), metastasis-free survival (MFS), disease-free survival (DFS), and overall survival (OS), using machine learning techniques. Materials and methods: A retrospective analysis of 173 patients with LACC treated between 2007 and 2021 was conducted. The study utilized machine learning techniques, including LASSO regression and Classification and Regression Tree (CART) analysis, to identify significant predictors of outcomes. Clinical data, tumor-related parameters, and treatment factors, along with IIs and body composition metrics (e.g., sarcopenic obesity), were incorporated into the models. Model performance was evaluated using ROC curves and AUC values. Results: Among 173 patients, hemoglobin (Hb) levels, ECOG performance status, and total protein emerged as primary prognostic indicators across multiple endpoints. For 2-year LC, patients with Hb &gt; 11.9 g\/dL had a rate of 95.1% compared to 73.6% in those with lower levels, with further stratification by ECOG status, ANRI, and total protein refining predictions. For 5-year LC, rates were 83.1% for Hb &gt; 11.5 g\/dL and 43.3% for lower levels. For 2-year MFS, ECOG 0 patients had an 88.1% rate compared to 73.8% for ECOG \u2265 1. In 2-year OS, Hb &gt; 11.9 g\/dL predicted a 95.1% rate, while \u226411.9 g\/dL correlated with 74.0%. IIs (ANRI, SIRI, MLR) demonstrated predictive value only within specific patient subgroups defined by the primary prognostic indicators. The model showed strong predictive accuracy, with AUCs ranging from 0.656 for 2-year MFS to 0.851 for 2-year OS. Conclusions: These findings underscore the value of integrating traditional prognostic factors with emerging markers to enhance risk stratification in LACC. The use of machine learning techniques like LASSO and CART demonstrated strong predictive capabilities, highlighting their potential to refine individualized treatment strategies. Prospective validation of these models is warranted to confirm their utility in clinical practice.<\/jats:p>","DOI":"10.3390\/jpm15040153","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:41:11Z","timestamp":1744710071000},"page":"153","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating Novel and Classical Prognostic Factors in Locally Advanced Cervical Cancer: A Machine Learning-Based Predictive Model (ESTHER Study)"],"prefix":"10.3390","volume":"15","author":[{"given":"Federica","family":"Medici","sequence":"first","affiliation":[{"name":"D\u00e9partement de Radioth\u00e9rapie, Gustave Roussy, 94 805 Villejuif, France"},{"name":"Radiation Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Ferioli","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Azienda Ospedaliero\u2014Universitaria di Ferrara, 44124 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9966-6342","authenticated-orcid":false,"given":"Arina Alexandra","family":"Zamfir","sequence":"additional","affiliation":[{"name":"Radiation Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milly","family":"Buwenge","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-201X","authenticated-orcid":false,"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, Responsible Research Hospital, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1276-5070","authenticated-orcid":false,"given":"Francesco","family":"Deodato","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, Responsible Research Hospital, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"UOC di Radioterapia Oncologica, Dipartimento Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"},{"name":"Division of Gynecologic Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"},{"name":"Division of Gynecologic Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Strigari","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bazzocchi","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5151-0866","authenticated-orcid":false,"given":"Stefania M. R.","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Service of Radiology, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), CH-6500 Lugano, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costanza Maria","family":"Donati","sequence":"additional","affiliation":[{"name":"Radiation Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Arcelli","sequence":"additional","affiliation":[{"name":"Radiation Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-3410","authenticated-orcid":false,"given":"Alessio Giuseppe","family":"Morganti","sequence":"additional","affiliation":[{"name":"Radiation Oncology, IRCCS Azienda Ospedaliero\u2014Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savino","family":"Cilla","sequence":"additional","affiliation":[{"name":"Medical Physics Unit, Responsible Research Hospital, 86100 Campobasso, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"EMBRACE Collaborative Group. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study","volume":"22","author":"Tanderup","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized Trials","volume":"26","author":"Vale","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_5","first-page":"711","article-title":"Management of recurrent cervical cancer","volume":"27","author":"Lai","year":"2004","journal-title":"Chang. Gung Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/ijgc-00009577-200707000-00013","article-title":"Long-term outcome and prognostic factors in patients with cervical carcinoma: A retrospective study","volume":"17","author":"Atahan","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2004.04.008","article-title":"Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: A Gynecologic Oncology Group Study","volume":"94","author":"Winter","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E","article-title":"The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix","volume":"86","author":"Grogan","year":"1999","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0093-7754(01)90215-5","article-title":"The effect of hemoglobin level on radiotherapy outcomes: The Canadian experience","volume":"28","author":"Thomas","year":"2001","journal-title":"Semin. Oncol."},{"key":"ref_10","first-page":"51","article-title":"Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study","volume":"12","author":"Koulis","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1158\/1055-9965.EPI-14-0146","article-title":"Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis","volume":"23","author":"Templeton","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3892\/mco.2016.1028","article-title":"Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy","volume":"5","author":"Haraga","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5468\/ogs.2019.62.1.35","article-title":"Prognostic significance of pretreatment lymphocyte percentage and age at diagnosis in patients with locally advanced cervical cancer treated with definite radiotherapy","volume":"62","author":"Jeong","year":"2019","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lee, J.W., and Seol, K.H. (2021). Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102199"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.21873\/anticanres.13973","article-title":"Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated with Concurrent Chemoradiotherapy","volume":"40","author":"Lee","year":"2020","journal-title":"Anticancer. Res."},{"key":"ref_16","first-page":"1555","article-title":"Pretreatment neutrophil: Lymphocyte ratio as a prognostic factor in cervical carcinoma","volume":"32","author":"Lee","year":"2012","journal-title":"Anticancer. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2939162","DOI":"10.1155\/2021\/2939162","article-title":"Neutrophil-to-Lymphocyte Ratio (NLR) and Monocyte-to-Lymphocyte Ratio (MLR) Predict Clinical Outcome in Patients with Stage IIB Cervical Cancer","volume":"2021","author":"Li","year":"2021","journal-title":"J. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10147-015-0807-6","article-title":"The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer","volume":"20","author":"Mizunuma","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/IGC.0000000000000741","article-title":"Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer","volume":"26","author":"Onal","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3740794","DOI":"10.1155\/2016\/3740794","article-title":"Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy","volume":"2016","author":"Wang","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cca.2018.05.025","article-title":"Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer","volume":"483","author":"Zhu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s12094-018-1991-4","article-title":"Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients","volume":"21","author":"Holub","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1136\/ijgc-2019-001050","article-title":"Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation","volume":"30","author":"Kim","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.2147\/CMAR.S178745","article-title":"Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients","volume":"10","author":"Gmyrek","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100539","DOI":"10.1016\/j.ctarc.2022.100539","article-title":"Pre-treatment hematological parameters as a cost effective predictive marker for response to concurrent chemo radiation in locally advanced cervical cancer","volume":"31","author":"Chauhan","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12935-016-0334-1","article-title":"Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma","volume":"16","author":"Li","year":"2016","journal-title":"Cancer Cell Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1080\/01635581.2020.1729820","article-title":"Prognostic Nutritional Index and Clinical Response in Locally Advanced Cervical Cancer","volume":"72","author":"Gangopadhyay","year":"2020","journal-title":"Nutr. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ferioli, M., Benini, A., Malizia, C., Forlani, L., Medici, F., Laghi, V., Ma, J., Galuppi, A., Cilla, S., and Buwenge, M. (2023). Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study). J. Pers. Med., 13.","DOI":"10.3390\/jpm13081229"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Medici, F., Ferioli, M., Forlani, L., Laghi, V., Ma, J., Cilla, S., Buwenge, M., Macchia, G., Deodato, F., and Vadal\u00e0, M. (2023). Decoding the Complexity of Systemic Inflammation Predictors in Locally Advanced Cervical Cancer, with Hemoglobin as the Hidden Key (the ESTHER Study). Cancers, 15.","DOI":"10.3390\/cancers15205056"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Medici, F., Ferioli, M., Cammelli, S., Forlani, L., Laghi, V., Ma, J., Cilla, S., Buwenge, M., Macchia, G., and Deodato, F. (2024). Sarcopenic Obesity in Cervical Carcinoma: A Strong and Independent Prognostic Factor beyond the Conventional Predictors (ESTHER Study\u2014AFRAID Project). Cancers, 16.","DOI":"10.3390\/cancers16050929"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/030089161209800407","article-title":"Daily on-line set-up correction in 3D-conformal radiotherapy: Is it feasible?","volume":"98","author":"Deodato","year":"2012","journal-title":"Tumori J."},{"key":"ref_32","unstructured":"Weir, C.B., and Jan, A. (2023, October 09). BMI Classification Percentile and Cut off Points, StatPearls, Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): An international, open-label, randomised, phase 3 trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"ENGOT-cx11\/GOG-3047\/KEYNOTE-A18 investigators. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): A randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(23)00479-5","article-title":"Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): A randomised, double-blind, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.2147\/IJGM.S442389","article-title":"An Energy-Efficient Test and Predictive Model for Recurrence After Radiotherapy in Localized Intermediate and Advanced Cervical Cancer Were Created Using Thymidine Kinase 1 in Conjunction with Inflammatory Markers and Tumor Markers","volume":"16","author":"Luo","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_40","first-page":"690","article-title":"Online ahead of print. Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging","volume":"39","author":"Hua","year":"2024","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xu, C., Liu, W., Zhao, Q., Zhang, L., Yin, M., Zhou, J., Zhu, J., and Qin, S. (2023). CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1287121"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.brachy.2022.06.007","article-title":"Brachytherapy outcome modeling in cervical cancer patients: A predictive machine learning study on patient-specific clinical, physical and dosimetric parameters","volume":"21","author":"Abdalvand","year":"2022","journal-title":"Brachytherapy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/CMAR.S365612","article-title":"Predictive Value of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Index on the Oncological Outcomes of Locally Advanced Cervical Cancer Patients","volume":"14","author":"Leetanaporn","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.2147\/CMAR.S336892","article-title":"Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging","volume":"13","author":"Zang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tang, Q., Li, X., and Sun, C.R. (2024). Predictive value of serum albumin levels on cancer survival: A prospective cohort study. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1323192"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Takenaka, Y., Takemoto, N., Yasui, T., Yamamoto, Y., Uno, A., Miyabe, H., Ashida, N., Shimizu, K., Nakahara, S., and Hanamoto, A. (2016). Transaminase activity predicts survival in patients with head and neck cancer. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164057"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chen, S.L., Xue, N., Wu, M.T., Chen, H., He, X., Li, J.P., Liu, W.L., and Dai, S.Q. (2016). Influence of preoperative serum aspartate aminotransferase (AST) level on the prognosis of patients with non-small cell lung cancer. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091474"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.21037\/jtd-20-3525","article-title":"Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy","volume":"13","author":"Alves","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/imt-2016-0138","article-title":"Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy","volume":"9","author":"Moreira","year":"2017","journal-title":"Immunotherapy"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1002\/cam4.4208","article-title":"Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: A retrospective study","volume":"10","author":"Herrmann","year":"2021","journal-title":"Cancer Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijrobp.2007.04.055","article-title":"Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: Evaluation of cost-effectiveness","volume":"69","author":"Forni","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000138979","article-title":"Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome","volume":"74","author":"Ferrandina","year":"2008","journal-title":"Oncology"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Jeong, S.Y., Chung, J.Y., Byeon, S.J., Kim, C.J., Lee, Y.Y., Kim, T.J., Lee, J.W., Kim, B.G., Chae, Y.L., and Oh, S.Y. (2021). Validation of Potential Protein Markers Predicting Chemoradioresistance in Early Cervical Cancer by Immunohistochemistry. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.665595"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/ijmm.2024.5374","article-title":"Promising predictive molecular biomarkers for cervical cancer (Review)","volume":"53","author":"Lizano","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Fleischmann, M., Chatzikonstantinou, G., Fokas, E., Wichmann, J., Christiansen, H., Strebhardt, K., R\u00f6del, C., Tselis, N., and R\u00f6del, F. (2021). Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers, 13.","DOI":"10.3390\/cancers13225748"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Cheung, E.S., and Wu, P.Y. (2025). Current Paradigm and Future Directions in the Management of Nodal Disease in Locally Advanced Cervical Cancer. Cancers, 17.","DOI":"10.3390\/cancers17020202"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/4\/153\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:15:07Z","timestamp":1760030107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/4\/153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["jpm15040153"],"URL":"https:\/\/doi.org\/10.3390\/jpm15040153","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}